Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 532 participants.
Also called NCT05820880
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 532 participants
- Sponsor
- Institut de Recherches Internationales Servier
- Registry
-
NCT05820880
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05820880. Randomized; double masking; primary purpose treatment. Start 2019-05-06 (actual); primary completion 2022-02-23 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension
- Condition
- Hypertension
- Intervention (Drug)
- Fixed [Per/Ind/Aml]
- Intervention (Drug)
- Free [Per/Ind + Aml]
- Lead sponsor
- Institut de Recherches Internationales Servier
Record details
- Record id
cardio:ct-nct05820880- Content hash
9fa735f0af0fac119d1f89c6a4345368a18800d2800d20fedfa9261b2414294d